期刊文献+

In vivo real-time imaging of gemcitabine-leaded growth inhibition in the orthotopic transplantation model of human pancreatic tumor 被引量:4

原文传递
导出
摘要 Human xenograft mouse models,which have been used in cancer research for over a century,provided significant advances for our understanding of this multifaceted family of diseases.Orthotopic transplantation tumor models are emerging as the preference for cancer research due to the increasing clinical relevance over subcutaneous mouse models.In this study,a stable luciferaseexpressed Capan-2 cell line was constructed and the expression of luciferase was tested.The results showed that the luminorescence intensity of Capan-2^(Luc) cells was associated with the number of cells and the minimal detectable cell population was 600 cells/well.We established an orthotopic transplantation model of pancreatic cancer using Capan-2^(Luc) cell line in athymic mice and investigated the inhibitory effects of gemcitabine(Gem)in vitro and in vivo.Optical imaging system was applied to evaluate the tumor growth of orthotopic transplantation model in vivo.The results suggested that the orthotopic transplantation model of pancreatic cancer was well established and the luminorescence intensity of Gem-treated group was markedly lower than that of control group with an inhibitory rate of 56.8%(P<0.001).Our orthotopic transplantation model of pancreatic cancer and real-time imaging observation method established in this study could be an ideal model and a useful tool for therapeutic approaches for pancreatic cancers.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS 2011年第4期220-225,共6页 药学学报(英文版)
基金 supported by the grants from National Basic Research Program of China(No.2009CB521807) National S&T Major Special Project on Major New Drug Innovation(No.2009ZX09301-003) State-level public welfare scientific research institutes for basic R&D special fund(No.IMBF201101).
  • 相关文献

参考文献2

二级参考文献18

  • 1陈中举,张燕玲,黄金瑛.荧光标记生物大分子及其应用[J].国外医学(生物医学工程分册),2004,27(6):348-352. 被引量:22
  • 2孙昉宪.肿瘤模型的最新进展——“转移鼠”模型[J].国外医学(肿瘤学分册),1996,23(5):287-290. 被引量:5
  • 3Trail PA,Bianchi AB.Monoclonal antibody drug conjugates in the treatment of cancer.Curr Opin Immunol,1999,11:584-588.
  • 4Hilderbrand SA,Weissleder R.Near-infrared fluorescence:application to in vivo molecular imaging.Curr Opin Chem Biol,2010,14:71-79.
  • 5Jiang S,Gnanasammandhan MK,Zhang Y.Optical imagingguided cancer therapy with fluorescent nanoparticles.J R Soc Interface,2010,7:3-18.
  • 6Zou P,Xu S,Wang A,et al.Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.Mol Pharm,2009,6:428-440.
  • 7Boghaert ER,Khandke K,Sridharan L,et al.Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy.Int J Onco,2006,28:675-684.
  • 8Adams GP,Weiner LM.Monoclonal antibody therapy of cancer.Nat Biothechnol,2005,23:1147-1157.
  • 9Kalofonos HP,Grivas PD.Monoclonal antibodies in the management of solid tumors.Curr Top Med Chem,2006,6:1687-1705.
  • 10Sharkey RM,Goldenberg DM.Targeted therapy of cancer:new prospects for antibodies and immunoconjugates.CA Cancer J Clin,2006,56:226-243.

共引文献12

同被引文献7

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部